Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (12): 766-766.
Previous Articles Next Articles
CHEN Congqin1, CHEN Zhiqiang1, CHEN Chunmei1, ZHANG Qiang2*
Received:2019-01-18
Revised:2019-01-18
Online:2018-12-20
Published:2019-01-18
CLC Number:
CHEN Congqin, CHEN Zhiqiang, CHEN Chunmei, ZHANG Qiang. One Case of Hallucination Induced by Levofloxacin Sodium Chloride Injection Combined with Nimesulide Tablets[J]. Chinese Journal of Pharmacovigilance, 2018, 15(12): 766-766.
| [1] 谢红莲. 滴速与盐酸左氧氟沙星注射液不良反应发生关系的探讨[J]. 医学理论与实践, 2012, 25(13):1637-1639. [2] 段小军, 谈平, 李艳娟. 左氧氟沙星注射液致血液透析患者精神异常1 例[J]. 中国药物警戒, 2016, 13(10):632-633. [3] 钟晗, 刘晓琰, 崔敏, 等. 155例喹诺酮类药品不良反应分析[J]. 中国药物警戒, 2016, 10(5):309-311. [4] 李焕芬, 胡月琴. 莫西沙星致眩晕与视物模糊[J]. 药物不良反应杂志, 2016, 18(2):149-150. [5] 张巍巍, 许琳, 耿长新, 等. 左氧氟沙星诱发分离(转换)性障碍[J]. 药物不良反应杂志, 2011, 13(6):379-380. [6] 单爱莲, 赵桂元, 钱思源. 左氧氟沙星不良反应的国内外文献个案调查与分析[J]. 中国临床药理学杂志, 2012, 28(3):212-217. [7] 管枚, 金朝辉, 杨娟. 282例左氧氟沙星不良反应报告分析[J]. 中国药物警戒, 2007, 4(3):158-161. [8] 梁雁, 鲁云兰. 左氧氟沙星注射液不良反应及相关因素[J]. 药物不良反应杂志, 2003,5(2):77-80. [9] Katsuro Yagawa.Latest industry information on the safety profile of levofloxacin in Japan[J]. Chemotherapy, 2001, 47(suppl 3):38. [10] 陈晓萌, 张梦, 刘凌燕. 调整1例出现药物不良反应患者治疗方案的分析[J]. 中国医药科学, 2014, 4(20):85-90. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
